ISSN: 1001-0602
EISSN: 1748-7838
2012 impact factor 10.526*
(Thomson Reuters, 2013)
Free Sample Issue
 

VOLUME 29 ISSUE 8(8,2019): 607-608

 

AIF: an acquired metabolic liability in lung cancer

 

Brandon Faubert1, Ralph J. DeBerardinis 1,2,3,4 and John D. Minna 5,6

 

1 Children’s Medical Center Research Institute, Dallas, TX, USA; 2Department of Pediatrics, Dallas, TX, USA; 3Eugene McDermott Center for Human Growth and Development, Dallas, TX, USA; 4Howard Hughes Medical Institute, Dallas, TX, USA; 5Hamon Center for Therapeutic Oncology Research, Dallas, TX, USA and 6Department of Internal Medicine and Simmons Cancer Center, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA

Correspondence:Brandon Faubert (Brandon.Faubert@UTSouthwestern.edu) or Ralph J. DeBerardinis (Ralph.DeBerardinis@UTSouthwestern.edu) or John D. Minna
(John.Minna@UTSouthwestern.edu)        

 

Apoptosis-inducing factor has two roles: acting as an apoptosis effector and maintaining mitochondrial metabolism. A recent study uncouples these roles and finds that only the mitochondrial functions are required for tumorigenesis in mice.

 

https://doi.org/10.1038/s41422-019-0197-9

 
 
Browse  153

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.
 
Home | Resources | Jobs | Contact Us
Copyright © 2013-2015 Institute of Biochemistry and Cell Biology, SIBS, CAS
您是第 位访问者,欢迎!
 沪ICP备05033115号